Unified Patent Court (UPC) analytics are now available. Check here

TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Nervous System Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Nervous System Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Nervous System Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Nervous System Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Nervous System Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Nervous System Drugs industry

EP4054620Glp-1 Receptor Agonists In DementiaNOVO NORDISKFeb 27, 2025GENERICS UK
EP4005555Methods For Ensuring Resuspension Of Paliperidone Palmitate FormulationsJANSSEN PHARMACEUTICAFeb 17, 2025HAMM&WITTKOPP PATENTANWALTE PARTMBB
EP4005555Methods For Ensuring Resuspension Of Paliperidone Palmitate FormulationsJANSSEN PHARMACEUTICAFeb 14, 2025ELKINGTON AND FIFE
EP4054620Glp-1 Receptor Agonists In DementiaNOVO NORDISKFeb 7, 2025SANDOZ
EP3848028Methods Of Treating Ocular ConditionsOYSTER POINT PHARMAFeb 6, 2025HOFFMANN EITLE
EP3038611Novel 2,4-Dinitrophenol Formulations And Methods Using SameYALE UNIVERSITYJan 17, 2025MITO PHARMACEUTICALS
EP4069368Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRSJan 15, 2025DORRIES
EP4216980C-Phycocyanin For Use In The Treatment And/Or Prevention Of Peripheral NeuropathyANILUR PHARMAJan 9, 2025ALGOSOURCE
EP3373972Compositions For Treating Spinal Muscular AtrophyF HOFFMANN LA ROCHEDec 20, 2024DR SCHON
EP3711758Use Of Carbamate Compound For Preventing, Alleviating Or Treating Absence Seizure Or Epilepsy Showing Absence SeizureSK BIOPHARMACEUTICALSDec 20, 2024DENNEMEYER & ASSOCIATES

To stay ahead in the competitive Nervous System Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Nervous System Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2234617Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
EP3744326Dec 6, 2023Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA9
EP2350096Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS8
EP2340828Jul 15, 2020Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep InhibitorNOVARTIS8
EP3280416Apr 22, 2020Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICALS8
EP2962686Apr 10, 2019Dosage Form Containing Oxycodone And NaloxoneEURO CELTIQUE7
EP2949335Jan 4, 2017Low Frequency Glatiramer Acetate TherapyYEDA RESEARCH6
EP3103443Jun 30, 2021Method For Treating Primary InsomniaNEURIM PHARMACEUTICALS6
EP2545939Dec 16, 2020Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of MeasuringBIOMARIN PHARMACEUTICAL5
EP2630962Jun 27, 2018Low Frequency Glatiramer Acetate TherapyYEDA RESEARCH5